Annual EBITDA
-$65.45 M
-$29.42 M-81.67%
31 December 2023
Summary:
Armata Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$65.45 million, with the most recent change of -$29.42 million (-81.67%) on 31 December 2023. During the last 3 years, it has fallen by -$45.01 million (-220.21%). ARMP annual EBITDA is now -1595.08% below its all-time high of -$3.86 million, reached on 31 December 2012.ARMP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$2.25 M
-$14.26 M-118.68%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$2.25 million, with the most recent change of -$14.26 million (-118.68%) on 30 September 2024. Over the past year, it has increased by +$27.52 million (+92.46%). ARMP quarterly EBITDA is now -116.75% below its all-time high of $13.40 million, reached on 30 September 2001.ARMP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$31.21 M
+$27.52 M+46.85%
30 September 2024
Summary:
Armata Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$31.21 million, with the most recent change of +$27.52 million (+46.85%) on 30 September 2024. Over the past year, it has increased by +$26.20 million (+45.63%). ARMP TTM EBITDA is now -10504.67% below its all-time high of $300.00 thousand, reached on 30 September 1993.ARMP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -81.7% | +92.5% | +45.6% |
| 3 y3 years | -220.2% | +56.0% | -39.8% |
| 5 y5 years | -541.3% | +64.9% | -255.2% |
ARMP EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -220.2% | at low | -118.7% | +92.5% | -42.4% | +57.9% |
| 5 y | 5 years | -541.3% | at low | -118.7% | +92.5% | -255.2% | +57.9% |
| alltime | all time | -1595.1% | at low | -116.8% | +95.4% | <-9999.0% | +57.9% |
Armata Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.25 M(-118.7%) | -$31.21 M(-46.9%) |
| June 2024 | - | $12.02 M(-152.5%) | -$58.73 M(-20.7%) |
| Mar 2024 | - | -$22.88 M(+26.4%) | -$74.07 M(+13.2%) |
| Dec 2023 | -$65.45 M(+81.7%) | -$18.10 M(-39.2%) | -$65.45 M(+14.0%) |
| Sept 2023 | - | -$29.76 M(+796.8%) | -$57.41 M(+59.3%) |
| June 2023 | - | -$3.32 M(-76.7%) | -$36.04 M(-13.7%) |
| Mar 2023 | - | -$14.26 M(+41.6%) | -$41.74 M(+15.9%) |
| Dec 2022 | -$36.02 M(+64.3%) | -$10.07 M(+20.0%) | -$36.03 M(+13.5%) |
| Sept 2022 | - | -$8.39 M(-7.1%) | -$31.73 M(+11.5%) |
| June 2022 | - | -$9.03 M(+5.6%) | -$28.45 M(+12.4%) |
| Mar 2022 | - | -$8.55 M(+48.2%) | -$25.32 M(+15.5%) |
| Dec 2021 | -$21.92 M(+7.3%) | -$5.77 M(+13.1%) | -$21.92 M(-1.8%) |
| Sept 2021 | - | -$5.10 M(-13.5%) | -$22.32 M(-1.1%) |
| June 2021 | - | -$5.90 M(+14.5%) | -$22.58 M(+7.7%) |
| Mar 2021 | - | -$5.15 M(-16.5%) | -$20.97 M(+2.6%) |
| Dec 2020 | -$20.44 M(+18.9%) | -$6.17 M(+15.3%) | -$20.44 M(+11.4%) |
| Sept 2020 | - | -$5.35 M(+24.9%) | -$18.34 M(-5.4%) |
| June 2020 | - | -$4.29 M(-7.3%) | -$19.39 M(+3.5%) |
| Mar 2020 | - | -$4.62 M(+13.4%) | -$18.74 M(+8.9%) |
| Dec 2019 | -$17.20 M(+68.5%) | -$4.08 M(-36.3%) | -$17.20 M(+95.7%) |
| Sept 2019 | - | -$6.40 M(+76.1%) | -$8.79 M(+125.0%) |
| June 2019 | - | -$3.63 M(+17.8%) | -$3.91 M(+21.0%) |
| Mar 2019 | - | -$3.08 M(-171.2%) | -$3.23 M(+4.1%) |
| Dec 2018 | -$10.21 M(+2.2%) | $4.33 M(-385.3%) | -$3.10 M(-68.0%) |
| Sept 2018 | - | -$1.52 M(-48.6%) | -$9.70 M(+9.8%) |
| June 2018 | - | -$2.96 M(-0.1%) | -$8.84 M(-8.7%) |
| Mar 2018 | - | -$2.96 M(+30.4%) | -$9.67 M(-3.1%) |
| Dec 2017 | -$9.98 M(-25.9%) | -$2.27 M(+247.5%) | -$9.98 M(+0.5%) |
| Sept 2017 | - | -$653.00 K(-82.8%) | -$9.93 M(-21.1%) |
| June 2017 | - | -$3.79 M(+16.2%) | -$12.59 M(+2.4%) |
| Mar 2017 | - | -$3.27 M(+47.4%) | -$12.29 M(-8.7%) |
| Dec 2016 | -$13.46 M(+36.0%) | -$2.22 M(-33.1%) | -$13.46 M(-4.5%) |
| Sept 2016 | - | -$3.31 M(-5.3%) | -$14.10 M(+7.6%) |
| June 2016 | - | -$3.50 M(-21.2%) | -$13.10 M(+8.0%) |
| Mar 2016 | - | -$4.44 M(+55.7%) | -$12.13 M(+22.6%) |
| Dec 2015 | -$9.90 M(-18.1%) | -$2.85 M(+22.8%) | -$9.90 M(+3.7%) |
| Sept 2015 | - | -$2.32 M(-8.2%) | -$9.54 M(-10.1%) |
| June 2015 | - | -$2.53 M(+14.8%) | -$10.62 M(-9.8%) |
| Mar 2015 | - | -$2.20 M(-11.9%) | -$11.76 M(-2.5%) |
| Dec 2014 | -$12.09 M(-80.4%) | -$2.50 M(-26.4%) | -$12.07 M(+32.4%) |
| Sept 2014 | - | -$3.39 M(-7.7%) | -$9.11 M(-83.3%) |
| June 2014 | - | -$3.67 M(+46.5%) | -$54.41 M(-13.5%) |
| Mar 2014 | - | -$2.51 M(-647.6%) | -$62.88 M(+2.1%) |
| Dec 2013 | -$61.60 M(+1495.5%) | $458.00 K(-100.9%) | -$61.60 M(-0.7%) |
| Sept 2013 | - | -$48.69 M(+301.0%) | -$62.06 M(+364.3%) |
| June 2013 | - | -$12.14 M(+891.2%) | -$13.37 M(+991.2%) |
| Mar 2013 | - | -$1.23 M(-193.0%) | -$1.23 M(-35.8%) |
| Dec 2012 | -$3.86 M(-67.2%) | - | - |
| Sept 2009 | - | $1.32 M(+147.6%) | -$1.91 M(-67.4%) |
| June 2009 | - | $532.00 K(-139.5%) | -$5.86 M(-41.1%) |
| Mar 2009 | - | -$1.35 M(-44.2%) | -$9.94 M(-15.6%) |
| Dec 2008 | -$11.77 M(-14.7%) | -$2.41 M(-8.3%) | -$11.77 M(-9.9%) |
| Sept 2008 | - | -$2.63 M(-25.9%) | -$13.06 M(-2.5%) |
| June 2008 | - | -$3.55 M(+11.7%) | -$13.40 M(-1.0%) |
| Mar 2008 | - | -$3.18 M(-14.1%) | -$13.54 M(-69.1%) |
| Dec 2007 | -$13.80 M | -$3.70 M(+24.7%) | -$43.80 M(+5.4%) |
| Sept 2007 | - | -$2.97 M(-19.6%) | -$41.56 M(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | -$3.69 M(-89.0%) | -$41.21 M(-36.5%) |
| Mar 2007 | - | -$33.44 M(+2200.1%) | -$64.89 M(+90.8%) |
| Dec 2006 | -$34.00 M(+108.4%) | -$1.45 M(-44.6%) | -$34.00 M(-4.9%) |
| Sept 2006 | - | -$2.63 M(-90.4%) | -$35.77 M(-4.5%) |
| June 2006 | - | -$27.36 M(+968.9%) | -$37.46 M(+153.5%) |
| Mar 2006 | - | -$2.56 M(-20.6%) | -$14.78 M(-9.4%) |
| Dec 2005 | -$16.32 M(+25.6%) | -$3.22 M(-25.3%) | -$16.32 M(+9.3%) |
| Sept 2005 | - | -$4.31 M(-7.9%) | -$14.94 M(+9.4%) |
| June 2005 | - | -$4.68 M(+14.2%) | -$13.65 M(+6.9%) |
| Mar 2005 | - | -$4.10 M(+122.9%) | -$12.76 M(-1.8%) |
| Dec 2004 | -$13.00 M(+109.8%) | -$1.84 M(-39.2%) | -$13.00 M(-15.7%) |
| Sept 2004 | - | -$3.03 M(-20.3%) | -$15.41 M(+29.3%) |
| June 2004 | - | -$3.80 M(-12.4%) | -$11.92 M(+7.7%) |
| Mar 2004 | - | -$4.33 M(+1.8%) | -$11.06 M(+78.6%) |
| Dec 2003 | -$6.19 M(-58.3%) | -$4.26 M(-1009.4%) | -$6.19 M(+138.1%) |
| Sept 2003 | - | $468.00 K(-115.9%) | -$2.60 M(-60.9%) |
| June 2003 | - | -$2.94 M(-650.6%) | -$6.64 M(-26.8%) |
| Mar 2003 | - | $534.00 K(-180.5%) | -$9.08 M(-39.0%) |
| Dec 2002 | -$14.87 M(-25.3%) | -$663.00 K(-81.5%) | -$14.87 M(-34.6%) |
| Sept 2002 | - | -$3.58 M(-33.4%) | -$22.76 M(+293.9%) |
| June 2002 | - | -$5.37 M(+2.1%) | -$5.78 M(+95.4%) |
| Mar 2002 | - | -$5.26 M(-38.5%) | -$2.96 M(+82.7%) |
| Dec 2001 | -$19.91 M(-53.0%) | -$8.55 M(-163.8%) | -$1.62 M(-94.7%) |
| Sept 2001 | - | $13.40 M(-625.4%) | -$30.77 M(-28.5%) |
| June 2001 | - | -$2.55 M(-35.0%) | -$43.02 M(-2.2%) |
| Mar 2001 | - | -$3.92 M(-89.6%) | -$43.97 M(+3.8%) |
| Dec 2000 | -$42.34 M(+345.7%) | -$37.70 M(-3369.5%) | -$42.34 M(+547.1%) |
| Sept 2000 | - | $1.15 M(-133.0%) | -$6.54 M(-37.7%) |
| June 2000 | - | -$3.50 M(+52.4%) | -$10.50 M(+10.5%) |
| Mar 2000 | - | -$2.30 M(+20.9%) | -$9.50 M(-1.1%) |
| Dec 1999 | -$9.50 M(+26.7%) | -$1.90 M(-32.1%) | -$9.60 M(+60.0%) |
| Sept 1999 | - | -$2.80 M(+12.0%) | -$6.00 M(-6.3%) |
| June 1999 | - | -$2.50 M(+4.2%) | -$6.40 M(-1.5%) |
| Mar 1999 | - | -$2.40 M(-241.2%) | -$6.50 M(-12.2%) |
| Dec 1998 | -$7.50 M(-43.6%) | $1.70 M(-153.1%) | -$7.40 M(-43.9%) |
| Sept 1998 | - | -$3.20 M(+23.1%) | -$13.20 M(+1.5%) |
| June 1998 | - | -$2.60 M(-21.2%) | -$13.00 M(-7.1%) |
| Mar 1998 | - | -$3.30 M(-19.5%) | -$14.00 M(-1.4%) |
| Dec 1997 | -$13.30 M(+30.4%) | -$4.10 M(+36.7%) | -$14.20 M(+12.7%) |
| Sept 1997 | - | -$3.00 M(-16.7%) | -$12.60 M(-4.5%) |
| June 1997 | - | -$3.60 M(+2.9%) | -$13.20 M(+5.6%) |
| Mar 1997 | - | -$3.50 M(+40.0%) | -$12.50 M(+5.9%) |
| Dec 1996 | -$10.20 M(+13.3%) | -$2.50 M(-30.6%) | -$11.80 M(-3.3%) |
| Sept 1996 | - | -$3.60 M(+24.1%) | -$12.20 M(+13.0%) |
| June 1996 | - | -$2.90 M(+3.6%) | -$10.80 M(+4.9%) |
| Mar 1996 | - | -$2.80 M(-3.4%) | -$10.30 M(+2.0%) |
| Dec 1995 | -$9.00 M(+28.6%) | -$2.90 M(+31.8%) | -$10.10 M(+7.4%) |
| Sept 1995 | - | -$2.20 M(-8.3%) | -$9.40 M(0.0%) |
| June 1995 | - | -$2.40 M(-7.7%) | -$9.40 M(+3.3%) |
| Mar 1995 | - | -$2.60 M(+18.2%) | -$9.10 M(+42.2%) |
| Dec 1994 | -$7.00 M(+40.0%) | -$2.20 M(0.0%) | -$6.40 M(-34.0%) |
| Sept 1994 | - | -$2.20 M(+4.8%) | -$9.70 M(+31.1%) |
| June 1994 | - | -$2.10 M(-2200.0%) | -$7.40 M(+42.3%) |
| Mar 1994 | - | $100.00 K(-101.8%) | -$5.20 M(0.0%) |
| Dec 1993 | -$5.00 M | -$5.50 M(-5600.0%) | -$5.20 M(-1833.3%) |
| Sept 1993 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| June 1993 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1993 | - | $100.00 K | $100.00 K |
FAQ
- What is Armata Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual EBITDA year-on-year change?
- What is Armata Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Armata Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals TTM EBITDA year-on-year change?
What is Armata Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ARMP is -$65.45 M
What is the all time high annual EBITDA for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$3.86 M
What is Armata Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ARMP annual earnings before interest, taxes, depreciation & amortization has changed by -$29.42 M (-81.67%)
What is Armata Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ARMP is -$2.25 M
What is the all time high quarterly EBITDA for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is $13.40 M
What is Armata Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ARMP quarterly earnings before interest, taxes, depreciation & amortization has changed by +$27.52 M (+92.46%)
What is Armata Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ARMP is -$31.21 M
What is the all time high TTM EBITDA for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is $300.00 K
What is Armata Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ARMP TTM earnings before interest, taxes, depreciation & amortization has changed by +$26.20 M (+45.63%)